5 results  1 of 1 

1 Transcriptomic Analysis of Papillary Thyroid Cancer: A Focus on Immune-Subtyping, Oncogenic Fusion, and Recurrence
Seung-Jin Park, Yea Eun Kang, Jeong-Hwan Kim, Jong-Lyul Park, Seon-Kyu Kim, Seung-Woo Baek, In Sun Chu, Shinae Yi, Seong Eun Lee, Young Joo Park, Eun-Jae Chung, Jin Man Kim, Hye Mi Ko, Je-Ryong Kim, Seung-Nam Jung, Ho-Ryun Won, Jae Won Chang, Bon Seok Koo, Seon-Young Kim
Clin Exp Otorhinolaryngol.2022;15(2):183-193.   Published online 2022 March 4     DOI: http://dx.doi.org/10.21053/ceo.2021.02215
      
2 Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non–Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
Hyojin Kim, Hyun Jung Kwon, Eun Sun Kim, Soohyeon Kwon, Kyoung Jin Suh, Se Hyun Kim, Yu Jung Kim, Jong Seok Lee, Jin-Haeng Chung
Cancer Res Treat.2022;54(2):424-433.   Published online 2021 July 7     DOI: http://dx.doi.org/10.4143/crt.2021.583
      
3 PD-L1 Testing in Non-small Cell Lung Cancer: Past, Present, and Future
Hyojin Kim, Jin-Haeng Chung
J Pathol Transl Med.2019;53(4):199-206.   Published online 2019 May 2     DOI: http://dx.doi.org/10.4132/jptm.2019.04.24
      
4 Long Pentraxin 3 as a Predictive Marker of Mortality in Severe Septic Patients Who Received Successful Early Goal-Directed Therapy
Sun Bean Kim, Kyoung Hwa Lee, Ji Un Lee, Hea Won Ann, Jin Young Ahn, Yong Duk Jeon, Jung Ho Kim, Nam Su Ku, Sang Hoon Han, Jun Yong Choi, Young Goo Song, June Myung Kim
Yonsei Med J.2017;58(2):370-379.   Published online 2017 January 16     DOI: http://dx.doi.org/10.3349/ymj.2017.58.2.370
      
5 Personalized Medicine in Breast Cancer: A Systematic Review
Sang-Hoon Cho, Jongsu Jeon, Seung Il Kim
J Breast Cancer.2012;15(3):265-272.   Published online 2012 September 28     DOI: http://dx.doi.org/10.4048/jbc.2012.15.3.265
      

 1 of 1